A hypodermic needle is a medical device used for injecting medications or withdrawing fluids from the body. It is a hollow needle that pierces the skin to deliver medication or extract fluids. The global hypodermic needles market has been growing steadily over the years, owing to the increasing demand for injectable drugs and the rising prevalence of chronic diseases.
Product Type:
The hypodermic needles market is segmented based on product type, end-user, and region. Based on product type, the market is segmented into safety hypodermic needles, non-safety hypodermic needles, and others. The safety hypodermic needles segment dominated the market in 2020, owing to the increasing demand for safe injection practices and the rising awareness regarding needlestick injuries.
End-User:
Based on end-user, the market is segmented into hospitals, clinics, ambulatory surgical centers, and others. The hospitals segment dominated the market in 2020, owing to the increasing number of hospital admissions and the rising demand for injectable drugs in hospitals.
Regional Analysis:
Based on the region, the hypodermic needles market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. North America dominated the market in 2020, owing to the presence of major players in the region and the increasing demand for injectable drugs. Asia Pacific is expected to witness significant growth during the forecast period, owing to the rising prevalence of chronic diseases and the increasing adoption of injectable drugs.
Key Players:
The key players operating in the hypodermic needles market include Becton, Dickinson and Company, Smiths Medical, Terumo Corporation, Nipro Medical Corporation, Cardinal Health, Inc., Hindustan Syringes & Medical Devices Ltd., Retractable Technologies, Inc., Gerresheimer AG, Vygon SA, and B. Braun Melsungen AG.
Order the sample copy of report @ https://www.persistencemarketresearch.com/samples/3881
Conclusion:
The global hypodermic needles market is expected to witness significant growth during the forecast period, owing to the increasing demand for injectable drugs and the rising prevalence of chronic diseases. The safety hypodermic needles segment dominated the market in 2020, and the hospitals segment was the largest end-user of hypodermic needles. North America dominated the market in 2020, and Asia Pacific is expected to witness significant growth during the forecast period.